26 Apr 2017 | 5:59 PM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
453.35
-3.95
(-0.86 %)
26 Apr 2017 | 04:01 PM
Change company
  • Open (Rs)
    457.40
  • Prev. close (Rs.)
    457.30
  • High (Rs.)
    461.00
  • Low (Rs.)
    450.50
  • 52W H (Rs.)
    466.10
  • 52W L (Rs.)
    305.05
  • Volume (Rs.)
    57693
  • MCap (Rs in Cr.)
    46,411.39
456.5
-1.15
(-0.25 %)
  • Open (Rs)
    455.60
  • High (Rs)
    461.30
  • Low (Rs)
    451.40
  • Prev. close(Rs)
    457.65
  • Contracts Tra.
    11,15,200
  • Turnover (Cr.)
    51
  • Open Interest
    21,87,200
  • Open Int. chg
    92,800.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
14.87
Operating Margin (%)
24.22
Gross Profit Margin (%)
21.15
Net Profit Margin (%)
15.47
Total Debt/Equity
0.39
Dividend payout Ratio (Net Profit)
25.89
Earning Retention Ratio
74.65

News

26 Apr 2017 - 17:21:00-Pharma major Cadila Healthcare Ltd on Wednesday said Zydus got final approval from the US health reg...
25 Apr 2017 - 15:34:00-Pharma major Cadila Healthcare Ltd on Tuesday said it has received final approval from the US health...
31 Mar 2017 - 09:35:00-Cadila Healthcare Limited has said that it has acquired all shares held by its subsidiary companies ...
08 Mar 2017 - 13:50:00-Pharma major Cadila Healthcare Ltd on Wednesday said it has received final approval from the US heal...

Announcements

25-Apr-2017
Cadila Healthcar - Updates
13-Apr-2017
Cadila Healthcar - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
10-Apr-2017
Cadila Healthcar - Shareholding for the Period Ended March 31 2017
10-Apr-2017
Cadila Healthcar - Statement Of Investor Complaints As On March 31 2017.
10-Apr-2017
Cadila Healthcar - Updates

Religare Research

26 Apr 2017 | 10:51 AM
Agri Fundamental and Technical report
26 Apr 2017 | 09:57 AM
The Indian rupee rose to the highest level in more than 20 months against the dollar, helped by stro...
26 Apr 2017 | 09:38 AM
• Gold falls as stocks gain after French election result • Oil dives, U.S. crude below $50 for first...
26 Apr 2017 | 09:05 AM
CRISIL's 11.9% YoY Revenue growth in Q1CY17 was driven by pick-up in the research business while Ope...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,405 189.90 82.48 0.70
10,00,405 189.90 30.40 0.70
10,00,405 189.90 82.48 0.70
10,00,405 189.90 21.95 0.70
10,00,405 189.90 85.23 0.70

Shareholding Pattern

       
Promotors74.79%
Mutual Funds/UTI3.49%
FI/Banks3.63%
Insurance3.63%
FII9.88%
Government0.15%
Others2.95%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,611.05(-1.31)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,555.00(-0.48)
3317
 Piramal Enterprises Ltd.
2,448.00(-2.76)
3356
 Alkem Laboratories Ltd.
1,950.00(-1.75)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Cadila Healthcare Ltd.4.4595.6045.65
NIFTY(S&P CNX)306.65749.10660.55
BSE SENSEX896.202,425.212,041.93
BSE 500576.931,289.741,074.47

Corporate Details

Key Personal
Apurva S Diwanji
Addnl.Independent Director
Pankaj R Patel
Chairman & Managing Director
Sharvil P Patel
Joint Managing Director
Key Address
Registered Office
Zydus Tower Satellite Cross Roads Sarkhej Gandhinagar Highway,Ahmedabad,Gujarat

Tel:079-26868100, Fax:079-26862365 26862366

investor.grievance@zyduscadila.com
http://www.zyduscadila.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :59 C Chowringhee Road 3rd Floor

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Cadila Healthcare Ltd. that will help you decide whether to buy, sell or hold Cadila Healthcare Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Cadila Healthcare Ltd.